Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03149094 · ClinicalTrials.gov registry record · NA

CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue

A NA study of HIV and Fatigue, sponsored by Medical University of South Carolina.

Completed
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT03149094 is a NA study of HIV and Fatigue that has completed, run by Medical University of South Carolina. The registered enrollment target is 30 participants, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03149094, a NA study of HIV and Fatigue, has completed, sponsored by Medical University of South Carolina.

COMPLETED
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to create a smartphone, tablet and web-based application to help people deal with stress. Stress often increases fatigue in people with HIV infection, so successfully dealing with stress could help reduce HIV-related fatigue. The study is being done at one site, the Medical University of South Carolina. Approximately 30 people will take part in this portion of the study.

Interventions

  • BEHAVIORAL CBSM-SMI
  • BEHAVIORAL CBSM-SMI control

Study Locations (1)

South Carolina

  • Medical University of South Carolina - Charleston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2017-04-27
Est. Completion 2018-06-30
Phase NA

What the Registry Record Tells You About NCT03149094

The ClinicalTrials.gov registry entry for NCT03149094 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 440-participant average among 303 other HIV trials with a reported enrollment target (93% lower). The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.

The record links to 4 conditions, with HIV appearing as the primary indexed condition, and to 2 interventions - of which CBSM-SMI is the first listed.

NCT03149094 reports 1 study location spanning 1 distinct geographic area - top geographies include South Carolina.

Frequently Asked Questions

What is clinical trial NCT03149094 about?

NCT03149094 is a clinical study titled "CBSM Intervention Via mHealth to Ameliorate HIV-related Fatigue". The purpose of this study is to create a smartphone, tablet and web-based application to help people deal with stress. Stress often increases fatigue in people with HIV infection, so successfully dealing with stress could help reduce HIV-related fatigue. The study is being done at one site, the Medi...

What is the current status of trial NCT03149094?

This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-04-27. Estimated completion is 2018-06-30.

What conditions does trial NCT03149094 study?

This clinical trial studies the following conditions: HIV, Fatigue, Human Immunodeficiency Virus, Stress Disorder.

What interventions are being tested in trial NCT03149094?

The interventions under investigation include: CBSM-SMI (BEHAVIORAL), CBSM-SMI control (BEHAVIORAL).

Who is sponsoring clinical trial NCT03149094?

This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03149094 being conducted?

This trial has 1 study location across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.